OVIT Financials 07/16/2014 12:37:15 OncoVista Inn

OVIT Financials 07/16/2014 12:37:15
OncoVista Innovative Therapies, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development 901 1,100 1,157 451
Sales, General and Admin. 622 881 1,044 1,948
Non-Recurring Items - - - -
Other - - - -
Operating Income (1,522) (1,981) (2,201) (2,398)
Income From Continuing Operations
Add'l Income/Expense Items 73 359 (4) 256
Earnings Before Interest and Tax (1,449) (1,622) (2,206) (2,143)
Interest Expense - 7 24 147
Earnings Before Tax (1,450) (1,629) (2,230) (2,290)
Income Tax - - - -
Minority Interest - - - (93)
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (1,450) (1,629) (2,230) (2,290)
Non Recurring Events
Discontinued Operations - - 204 12,300
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (1,450) (1,629) (2,025) 10,103
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (1,450) (1,629) (2,025) 10,103